167 related articles for article (PubMed ID: 30708041)
1. Prostate cancer-specific hallmarks of amino acids metabolism: Towards a paradigm of precision medicine.
Strmiska V; Michalek P; Eckschlager T; Stiborova M; Adam V; Krizkova S; Heger Z
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):248-258. PubMed ID: 30708041
[TBL] [Abstract][Full Text] [Related]
2. Relation of exposure to amino acids involved in sarcosine metabolic pathway on behavior of non-tumor and malignant prostatic cell lines.
Heger Z; Gumulec J; Cernei N; Polanska H; Raudenska M; Masarik M; Eckschlager T; Stiborova M; Adam V; Kizek R
Prostate; 2016 May; 76(7):679-90. PubMed ID: 26847870
[TBL] [Abstract][Full Text] [Related]
3. Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer.
Schcolnik-Cabrera A; Juárez-López D
Cell Oncol (Dordr); 2022 Oct; 45(5):831-859. PubMed ID: 36036882
[TBL] [Abstract][Full Text] [Related]
4. Serine, glycine and one‑carbon metabolism in cancer (Review).
Pan S; Fan M; Liu Z; Li X; Wang H
Int J Oncol; 2021 Feb; 58(2):158-170. PubMed ID: 33491748
[TBL] [Abstract][Full Text] [Related]
5. Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer--a large nested case-control study within the JANUS cohort in Norway.
de Vogel S; Ulvik A; Meyer K; Ueland PM; Nygård O; Vollset SE; Tell GS; Gregory JF; Tretli S; Bjørge T
Int J Cancer; 2014 Jan; 134(1):197-206. PubMed ID: 23797698
[TBL] [Abstract][Full Text] [Related]
6. Precision medicine for advanced prostate cancer.
Mullane SA; Van Allen EM
Curr Opin Urol; 2016 May; 26(3):231-9. PubMed ID: 26909474
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs.
Schuster DM; Nanni C; Fanti S
J Nucl Med; 2016 Oct; 57(Suppl 3):61S-66S. PubMed ID: 27694174
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Metabolic targets for potential prostate cancer therapeutics.
Twum-Ampofo J; Fu DX; Passaniti A; Hussain A; Siddiqui MM
Curr Opin Oncol; 2016 May; 28(3):241-7. PubMed ID: 26907571
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and Amino Acid Alterations of the Tumor Microenvironment.
Stepka P; Vsiansky V; Raudenska M; Gumulec J; Adam V; Masarik M
Curr Med Chem; 2021; 28(7):1270-1289. PubMed ID: 32031065
[TBL] [Abstract][Full Text] [Related]
11. Importance of the mitochondrial amino acid pool in the sensitivity of erythroid cells to chloramphenicol: role of glycine and serine.
Abou-Khalil S; Abou-Khalil WH; Whitney PL; Yunis AA
Pharmacology; 1987; 35(6):308-16. PubMed ID: 3124141
[TBL] [Abstract][Full Text] [Related]
12. Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.
Wang Q; Tiffen J; Bailey CG; Lehman ML; Ritchie W; Fazli L; Metierre C; Feng YJ; Li E; Gleave M; Buchanan G; Nelson CC; Rasko JE; Holst J
J Natl Cancer Inst; 2013 Oct; 105(19):1463-73. PubMed ID: 24052624
[TBL] [Abstract][Full Text] [Related]
13. Metabolic signatures of malignant progression in prostate epithelial cells.
Teahan O; Bevan CL; Waxman J; Keun HC
Int J Biochem Cell Biol; 2011 Jul; 43(7):1002-9. PubMed ID: 20633696
[TBL] [Abstract][Full Text] [Related]
14. Amino Acid Profiles of Serum and Urine in Search for Prostate Cancer Biomarkers: a Pilot Study.
Dereziński P; Klupczynska A; Sawicki W; Pałka JA; Kokot ZJ
Int J Med Sci; 2017; 14(1):1-12. PubMed ID: 28138303
[TBL] [Abstract][Full Text] [Related]
15. Energy metabolism in cancer cells: how to explain the Warburg and Crabtree effects?
Dell' Antone P
Med Hypotheses; 2012 Sep; 79(3):388-92. PubMed ID: 22770870
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Evaluation of
Piert M; Shao X; Raffel D; Davenport MS; Montgomery J; Kunju LP; Hockley BG; Siddiqui J; Scott PJH; Chinnaiyan AM; Rajendiran T
J Nucl Med; 2017 Aug; 58(8):1216-1223. PubMed ID: 28302759
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Alterations in Renal and Prostate Cancer.
Ciccarese C; Santoni M; Massari F; Modena A; Piva F; Conti A; Mazzucchelli R; Cheng L; Lopez-Beltran A; Scarpelli M; Tortora G; Montironi R
Curr Drug Metab; 2016; 17(2):150-5. PubMed ID: 26467063
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.
Lucarelli G; Rutigliano M; Galleggiante V; Giglio A; Palazzo S; Ferro M; Simone C; Bettocchi C; Battaglia M; Ditonno P
Expert Rev Mol Diagn; 2015; 15(9):1211-24. PubMed ID: 26174441
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.
Wang Q; Bailey CG; Ng C; Tiffen J; Thoeng A; Minhas V; Lehman ML; Hendy SC; Buchanan G; Nelson CC; Rasko JE; Holst J
Cancer Res; 2011 Dec; 71(24):7525-36. PubMed ID: 22007000
[TBL] [Abstract][Full Text] [Related]
20. Biosynthetic energy cost for amino acids decreases in cancer evolution.
Zhang H; Wang Y; Li J; Chen H; He X; Zhang H; Liang H; Lu J
Nat Commun; 2018 Oct; 9(1):4124. PubMed ID: 30297703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
